Molecular formula: | C56H87NO16 |
Average mass: | 1030.303 |
Monoisotopic mass: | 1029.602486 |
ChemSpider ID: | 21468899 |
14 of 15 defined stereocentres
Double-bond stereo
Wikipedia
(1R,2R,4S)-4-{(2R)-2-[(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,35R)-1,18-Dihydroxy-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-2,3,10,14,20-pentaoxo-11,36-dioxa-4-azatricyclo[30.3.1.0~4,9~] hexatriaconta-16,24,26,28-tetraen-12-yl]propyl}-2-methoxycyclohexyl 3-hydroxy-2-(hydroxymethyl)-2-methylpropanoate
[ACD/IUPAC Name](1R,2R,4S)-4-{(2R)-2-[(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,35R)-1,18-Dihydroxy-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-2,3,10,14,20-pentaoxo-11,36-dioxa-4-azatricyclo[30.3.1.0~4,9~] hexatriaconta-16,24,26,28-tetraen-12-yl]propyl}-2-methoxycyclohexyl-3-hydroxy-2-(hydroxymethyl)-2-methylpropanoat
[German]
[ACD/IUPAC Name]162635-04-3
[RN]3-Hydroxy-2-(hydroxyméthyl)-2-méthylpropanoate de (1R,2R,4S)-4-{(2R)-2-[(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,35R)-1,18-dihydroxy-19,30-diméthoxy-15,17,21,23,29,35-hexaméthyl-2,3,10,14,20 -pentaoxo-11,36-dioxa-4-azatricyclo[30.3.1.0~4,9~]hexatriaconta-16,24,26,28-tétraén-12-yl]propyl}-2-méthoxycyclohexyle
[French]
[ACD/IUPAC Name]42-[3-hydroxy-2-(hydroxymethyl)-2-methylpropanoate]-Rapamycin
MFCD00934421
[MDL number]Propanoic acid, 3-hydroxy-2-(hydroxymethyl)-2-methyl-, (1R,2R,4S)-2-methoxy-4-[(2R)-2-[(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,26R,27R,34aS)-1,4,5,6,9,10,11,12,13,14,21,22,23,24,25,26,27,28,29,31,32, 33,34,34a-tetracosahydro-9,27-dihydroxy-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-1,5,11,28,29-pentaoxo-23,27-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontin-3-yl]propyl]cyclohexyl ester
[ACD/Index Name]temsirolimus
[French]
[INN]temsirólimus
[Spanish]
[INN]temsirolimusum
[Latin]
[INN]Torisel
темсиролимус
[Russian]
[INN]تامسيروليموس
[Arabic]
[INN]坦罗莫司
[Chinese]
[INN](1R,2R,4S)-4-[(2R)-2-[(1R,9S,12S,15R,18R,19R,21R,23S,30S,32S,35R)-1,18-dihydroxy-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-2,3,10,14,20-pentaoxo-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-
(1R,2R,4S)-4-[(2R)-2-[(1R,9S,12S,15R,18R,19R,21R,23S,30S,32S,35R)-1,18-dihydroxy-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-2,3,10,14,20-pentaoxo-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraen-12-yl]propyl]-2-methoxycyclohexy
(1R,2R,4S)-4-[(2R)-2-[(1R,9S,12S,15R,18R,19R,21R,23S,30S,32S,35R)-1,18-dihydroxy-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-2,3,10,14,20-pentaoxo-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraen-12-yl]propyl]-2-methoxycyclohexyl 3-hydroxy-2-(hydroxymethyl)-2-methylpropanoate
16,24,26,28-tetraen-12-yl]propyl]-2-methoxycyclohexyl 3-hydroxy-2-(hydroxymethyl)-2-methylpropanoate
42-[3-Hydroxy-2-(hydroxymethyl)-2-methylpropanoate]rapamycin
42-[3-Hydroxy-2-methylpropanoate
99%
MTOR_HUMAN
RAPAMYCIN
Rapamycin 42-[3-hydroxy-2(hydroxymethyl)-2-methylpropanoate]
Rapamycin 42-[3-hydroxy-2-(hydroxymethyl)-2-methylpropanoate
Rapamycin, 42-[3-hydroxy-2-(hydroxymethyl)-2-methylpropanoate]
Serine/threonine-protein kinase mTOR
Torisel®